Overcoming Barriers to Accessibility for Gene Therapies: The Need for Scalable, Cost-Efficient Biomanufacturing Strategies
Scalable solutions for the future of gene therapies
Learn moreDiscover our library
Scalable solutions for the future of gene therapies
Learn more
Engineered to scale bioprocessing operations into commercial manufacturing, the scale-X™ nitro controller
delivers flexible, low-footprint, and cost-effective automation for vaccine and viral vectors production.
Successful expansion of MSCs using Rooster Bio’s xeno-free MSC platform and scale-X™ fixed-bed bioreactor
Learn more
Mastering scalable process design with the scale-X™ Technology
Learn more
Read more about the potential of next-generation gas exchange technology.
Learn more
Discover how the scale-X™ platform combines theoretical rigor and cutting-edge technology to redefine the standards of bioreactor design.
Learn more
Explore how scale-X™ bioreactors overcome bioprocessing challenges and improve scalability in bioproduction.
Learn more
The 0.5 m² scale-X™ nexo bioreactor redefines what’s possible in early-stage research – delivering premium sophistication in a compact design.
Download
This innovative approach estimates cell number inside your scale-X™ bioreactor without the need for direct cell sampling, ensuring optimal productivity and efficiency in your workflow.
Download
Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Learn more
A promising alternative for scaled up production of cultivated fish
Learn more
Tackle the challenges in GMP Lentiviral virus production processes
Learn more
A process transfer of lentiviral vector production with adherent HEK293T cells from a conventional system to a novel fixed-bed bioreactor
Learn more
Wondering what it would mean to intensify your seed expansion process using the scale-X cell collect module?
Learn more
Deep dive into scaling viral manufacturing cost-effectively
Learn more
Discover how Univercells Technologies’ scale-X™ fixed-bed bioreactors achieved 2-fold increase in EV productivity enabling scalable production from proof-of-concept to large-scale continuous manufacturing
Learn more
The process optimization for AAV harvest contributes to high product recovery, small volumes, reduced host cell impurities and increased full/empty capsid ratio to address time and capacity gaps.
Learn more
Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms
Learn more
Innovative, scalable-by-design fixed-bed technology addresses limitations associated with stirred-tank bioreactors – Tech transfer study by CDMO Exothera
Learn more
The scale-X™ bioreactors’ design and performance features allow for linear predictability for process parameter scale-up
Learn more
Achieve your goal in biological processes by improving development troubleshooting, focusing on root cause analysis.
Learn more
Achieve 3-fold increase in AAV-2 cell-specific productivity using a suspension HEK293F cell line in the scale-X™ structured fixed-bed bioreactor
Learn more
Implementation of a metabolite-based cell density estimation and evaluation of harvest strategies for Lentivirus production with HEK293T cells
Learn more
Meet capacity challenges growing a suspension HEK293 cell line in serum-free conditions to produce an AAV-2 product in high quantities with a scale-X™ fixed-bed bioreactor
Learn more
Recirculation and perfusion are two advantageous methods for supplying medium nutrients to the cells in the scale-X™ structured fixed-bed bioreactor and for harvesting the cell-mediated product.
Learn more
Case study for HEK293 cell harvest from fixed-bed fibers
Download
The role of intensification and integration in rapid deployment of large viral production capacity
Download
Streamlined bioreactor-to-bioreactor seed train
Learn more
Highly productive lentivirus manufacture using the scale-X™ technology
Learn more
Scalable and high-productivity manufacture of advanced therapies
Download